| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/24/2008 | EP1276462B1 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 09/24/2008 | CN101272796A Use of at least one avermectin or milbemycin in the treatment of ophthalmic pathologies |
| 09/24/2008 | CN101272765A Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 09/24/2008 | CN101269221A Medicament sustained-release carrier for eyes with cooperation treatment function |
| 09/24/2008 | CN101269220A Rapamycin eye-in implantation type medicine release system with bletilla striata glue as carrier |
| 09/24/2008 | CN101269156A Chinese medicinal composition for treating eye disease |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma |
| 09/23/2008 | US7427615 3-substituted-4-pyrimidone derivatives |
| 09/23/2008 | US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 09/23/2008 | US7427608 Protection against and treatment of hearing loss |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 09/23/2008 | CA2582676A1 Building structure and components thereof |
| 09/23/2008 | CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient |
| 09/23/2008 | CA2416169C Compositions containing therapeutically active components having enhanced solubility |
| 09/23/2008 | CA2378390C Tixocortol pivalate suspension, collutorium based on it and packaging containing it |
| 09/23/2008 | CA2375679C Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 09/23/2008 | CA2371393C Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 09/21/2008 | CA2676401A1 Stable pharmaceutical compositions and methods of making and using same |
| 09/18/2008 | WO2008111632A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative |
| 09/18/2008 | WO2008111630A1 Pirenoxine-containing suspension-type aqueous preparation |
| 09/18/2008 | WO2008111590A2 Ampa and nmda receptor antagonists for neurodegenerative diseases |
| 09/18/2008 | WO2008111497A1 Prophylactic or therapeutic agent for ophthalmic disease associated with oxidative stress, comprising triterpenoid as active ingredient |
| 09/18/2008 | WO2008029276A8 Compositions and methods for the treatment of ophthalmic disease |
| 09/18/2008 | US20080227983 Piperidine derivatives and process for their production |
| 09/18/2008 | US20080227859 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227789 5-(quinoxalin-2-yl)-N2-(3,4,5-trimethoxyphenyl)thiazole-2,4-diamine; useful in inhibiting the activity of the receptor protein tyrosine kinase Axl; rheumatoid arthritis, vascular disease, vascular injury, psoriasis, visual impairment due to macular degeneration, diabetic retinopathy, retinopathy |
| 09/18/2008 | US20080227752 Methods to Inhibit Histone Acetyltransferase Using Glycosaminoglycans |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227692 Containing angiopoietin 1 and/or Fibulin 5; diabetic retinopathy, age related macular degeneration; inducing angiogenesis, enhancing endothelial cell survival, preventing vascular leakage |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | CA2680222A1 Methods of treating ophthalmic diseases |
| 09/17/2008 | EP1970370A1 Amorphous form of 1,2-dihydropyridine compound |
| 09/17/2008 | EP1970078A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball |
| 09/17/2008 | EP1970070A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/17/2008 | EP1968646A2 A predictive tool for hyaluronidase treatment success |
| 09/17/2008 | EP1968609A2 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds |
| 09/17/2008 | EP1968594A2 Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema |
| 09/17/2008 | EP1409477B1 Piperidine derivatives as nmda receptor antagonists |
| 09/17/2008 | EP1307450B1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
| 09/17/2008 | EP1297838B1 Pralmorelin-containing nasal drop preparations |
| 09/17/2008 | EP1202736B1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/17/2008 | CN101267824A Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 09/17/2008 | CN101265299A Biologically active peptides from functional domains of bactericidal permeability-increasing protein and uses thereof |
| 09/17/2008 | CN101264230A Chinese medicinal composition for treating optic atrophy and preparation thereof |
| 09/17/2008 | CN101264167A Compound eyesight-improving Chinese medicine |
| 09/17/2008 | CN101264131A Chinese medicine extracting liquid eye plaster and preparation thereof |
| 09/17/2008 | CN101264073A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264072A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264053A Oxybuprocaine hydrochloride eye drops and preparation thereof |
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418551C Ready prepared chinese medicine 'erjingling' drops for treating tympanitis and its preparation method |
| 09/17/2008 | CN100418536C Ophthalmic pharmaceutical composition for resisting fungus |
| 09/17/2008 | CN100418530C Ketoconazole eye drops and fabricating method thereof |
| 09/16/2008 | US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425560 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/16/2008 | CA2376193C Therapeutic agent comprising a botulinum neurotoxin |
| 09/16/2008 | CA2331605C The use of a vital dye for facilitating surgical procedures for cataract extraction |
| 09/16/2008 | CA2295483C Aliphatic propargylamines as cellular rescue agents |
| 09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 09/12/2008 | WO2008109397A2 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions |
| 09/12/2008 | WO2008108322A2 Composition and method for protecting mitochondria |
| 09/12/2008 | WO2008027796A3 Compositions and methods for treating or preventing glaucoma or progression thereof |
| 09/11/2008 | US20080221208 9-Cis- or 11-cis-retinyl succinate, citrate, ketoglutarate, fumarate, malate or oxaloacetate; administering to vertebrate having an endogenous retinoid deficiency; vision defects; 9-cis-retinyl acetate or 9-cis-retinyl succinate; photoreceptor stabilizers; macular degeneration |
| 09/11/2008 | US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds |
| 09/11/2008 | US20080221184 angiotensin II antagonist and a prostaglandin which is unoprostone or latanoprost; superior intraocular pressure lowering effect |
| 09/11/2008 | US20080221155 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 09/11/2008 | US20080221064 Pharmaceutical composition for dry eye, which remains on the cornea and exhibits a humectant effect for a longer period |
| 09/11/2008 | US20080221050 Genetic polymorphisms linked to optic neuropathy including glaucoma and Leber's disease; point mutations; enothelins; angiotensins; gene expression inhibition |
| 09/11/2008 | US20080221036 Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/11/2008 | US20080221030 Inhibition of Wet Type Age Related Macular Degeneration (Amd) by Adiponectin or Acrp 30 |
| 09/11/2008 | US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 09/11/2008 | US20080220106 Posses antibiotic, antiviral, antimicotic, and antiseptic activity; dissolving, disaggregating and removing ear wax |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080220049 Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/10/2008 | EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 09/10/2008 | EP1967206A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967205A2 Anti-IgE vaccines |
| 09/10/2008 | EP1966378A2 Rnai-mediated inhibition of hif1a for treatment of ocular angiogenesis |
| 09/10/2008 | EP1771181B1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 09/10/2008 | EP1551417B1 Three layer tear formulation |
| 09/10/2008 | EP1368302B1 Novel amino dicarboxylic acid derivatives |
| 09/10/2008 | CN101262887A Prevention and treatment of ophthalmic complications of diabetes |
| 09/10/2008 | CN101262886A Formulation and method for administration of ophthalmologically active agents |
| 09/10/2008 | CN101262872A Novel inhibitor of vascular endothelial growth factor expression |
| 09/10/2008 | CN101262855A Method of treatment or prevention of age-related macular degeneration |
| 09/10/2008 | CN101260398A Nerve growth factor gene positioning reconstruction animal and its preparation method and application |
| 09/10/2008 | CN101260149A Streptococcus antigens |
| 09/10/2008 | CN101259280A Biodegradable ocular implant |
| 09/10/2008 | CN101259153A Tribulus total steroid saponin and preparation thereof |